Patient and health care delays in large (class T3-T4) oral, oropharyngeal, and laryngeal carcinomas.
cancer
head and neck
health care delay
patient delay
treatment delay
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
18
08
2022
accepted:
16
01
2023
medline:
7
4
2023
pubmed:
8
3
2023
entrez:
7
3
2023
Statut:
ppublish
Résumé
Head and neck cancers (HNCs) are often diagnosed at an advanced stage. We investigated the lengths and factors associated with patient, primary health care (PHC), and specialist care (SC) delays in T3-T4 oral, oropharyngeal, and laryngeal cancer. A nationwide prospective questionnaire-based study (n = 203) with the 3-year long data collection period. The median patient, PHC and SC delays were 58, 13, and 43 days, respectively. Lower level of education, heavy alcohol use, hoarseness, difficulties breathing, and eventual palliative treatment associated with a longer patient delay. A lump on the neck or facial swelling associated with a shorter PHC delay. Conversely, if symptoms were treated as an infection, PHC delay was longer. The treatment modality and tumor site affected SC delay. Patient delay stands as the most notable factor contributing to delays before treatment. HNC symptom awareness thus remains especially important among HNC risk groups.
Sections du résumé
BACKGROUND
Head and neck cancers (HNCs) are often diagnosed at an advanced stage. We investigated the lengths and factors associated with patient, primary health care (PHC), and specialist care (SC) delays in T3-T4 oral, oropharyngeal, and laryngeal cancer.
METHODS
A nationwide prospective questionnaire-based study (n = 203) with the 3-year long data collection period.
RESULTS
The median patient, PHC and SC delays were 58, 13, and 43 days, respectively. Lower level of education, heavy alcohol use, hoarseness, difficulties breathing, and eventual palliative treatment associated with a longer patient delay. A lump on the neck or facial swelling associated with a shorter PHC delay. Conversely, if symptoms were treated as an infection, PHC delay was longer. The treatment modality and tumor site affected SC delay.
CONCLUSIONS
Patient delay stands as the most notable factor contributing to delays before treatment. HNC symptom awareness thus remains especially important among HNC risk groups.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1215-1225Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15(9):994-1001. doi:10.1634/theoncologist.2009-0289
Waaijer A, Terhaard CH, Dehnad H, et al. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66(3):271-276. doi:10.1016/s0167-8140(03)00036-7
Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169-178. doi:10.1200/jco.2015.61.5906
Schoonbeek RC, Zwertbroek J, Plaat BEC, et al. Determinants of delay and association with outcome in head and neck cancer: a systematic review. Eur J Surg Oncol. 2021;47(8):1816-1827. doi:10.1016/j.ejso.2021.02.029
Seoane J, Alvarez-Novoa P, Gomez I, et al. Early oral cancer diagnosis: the Aarhus statement perspective. A systematic review and meta-analysis. Head Neck. 2016;38(Suppl 1):E2182-E2189. doi:10.1002/hed.24050
Advancement in cancer treatment between 2010-2020. Report by working committee (in Finnish). Ministry of Social Affairs and Health. http://urn.fi/URN:ISBN:978-952-00-2971-5. Accessed 26 January 2022
Roennegaard AB, Rosenberg T, Bjørndal K, Sørensen JA, Johansen J, Godballe C. The Danish Head and Neck Cancer fast-track program: a tertiary cancer centre experience. Eur J Cancer. 2018;90:133-139. doi:10.1016/j.ejca.2017.10.038
Stefanuto P, Doucet JC, Robertson C. Delays in treatment of oral cancer: a review of the current literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):424-429. doi:10.1016/j.oooo.2013.12.407
Varela-Centelles P, Seoane J, Lopez-Cedrun JL, et al. The length of patient and primary care time interval in the pathways to treatment in symptomatic oral cancer. A quantitative systematic review. Clin Otolaryngol. 2018;43(1):164-171. doi:10.1111/coa.12919
Nieminen M, Aro K, Jouhi L, Bäck L, Mäkitie A, Atula T. Causes for delay before specialist consultation in head and neck cancer. Acta Oncol. 2018;57(12):1677-1686. doi:10.1080/0284186x.2018.1497297
Kassirian S, Dzioba A, Hamel S, et al. Delay in diagnosis of patients with head-and-neck cancer in Canada: impact of patient and provider delay. Curr Oncol. 2020;27(5):e467-e477. doi:10.3747/co.27.6547
Noonan B. Understanding the reasons why patients delay seeking treatment for oral cancer symptoms from a primary health care professional: an integrative literature review. Eur J Oncol Nurs. 2014;18(1):118-124. doi:10.1016/j.ejon.2013.07.005
Akram M, Siddiqui SA, Karimi AM. Patient related factors associated with delayed reporting in oral cavity and oropharyngeal cancer. Int J Prev Med. 2014;5(7):915-919.
Rogers SN, Pabla R, McSorley A, Lowe D, Brown JS, Vaughan ED. An assessment of deprivation as a factor in the delays in presentation, diagnosis and treatment in patients with oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2007;43(7):648-655. doi:10.1016/j.oraloncology.2006.08.001
Rozniatowski O, Reich M, Mallet Y, Penel N, Fournier C, Lefebvre JL. Psychosocial factors involved in delayed consultation by patients with head and neck cancer. Head Neck. 2005;27(4):274-280. doi:10.1002/hed.20157
Brouha XD, Tromp DM, Hordijk GJ, Winnubst JA, de Leeuw JR. Oral and pharyngeal cancer: analysis of patient delay at different tumor stages. Head Neck. 2005;27(11):939-945. doi:10.1002/hed.20270
Tromp DM, Brouha XD, De Leeuw JR, Hordijk GJ, Winnubst JA. Psychological factors and patient delay in patients with head and neck cancer. Eur J Cancer. 2004;40(10):1509-1516. doi:10.1016/j.ejca.2004.03.009
Brouha X, Tromp D, Hordijk GJ, Winnubst J, De Leeuw R. Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol. 2005;125(5):552-556. doi:10.1080/00016480510028456
Onizawa K, Nishihara K, Yamagata K, Yusa H, Yanagawa T, Yoshida H. Factors associated with diagnostic delay of oral squamous cell carcinoma. Oral Oncol. 2003;39(8):781-788. doi:10.1016/s1368-8375(03)00075-7
Nieminen M, Atula T, Bäck L, Mäkitie A, Jouhi L, Aro K. Factors influencing patient and health care delays in oropharyngeal cancer. J Otolaryngol Head Neck Surg. 2020;49(1):22. doi:10.1186/s40463-020-00413-w
Väisänen JA, Syrjälä AM, Pesonen PR, Pukkila MJ, Koivunen PT, Alho OP. Characteristics and medical-care-seeking of head and neck cancer patients: a population-based cross-sectional survey. Oral Oncol. 2014;50(8):740-745. doi:10.1016/j.oraloncology.2014.04.009
Franco J, Elghouche AN, Harris MS, Kokoska MS. Diagnostic delays and errors in head and neck cancer patients: opportunities for improvement. Am J Med Qual. 2017;32(3):330-335. doi:10.1177/1062860616638413
Brouha XD, Tromp DM, Koole R, Hordijk GJ, Winnubst JA, de Leeuw JR. Professional delay in head and neck cancer patients: analysis of the diagnostic pathway. Oral Oncol. 2007;43(6):551-556. doi:10.1016/j.oraloncology.2006.06.002
Kiong KL, Diaz EM, Gross ND, Diaz EM Jr, Hanna EY. The impact of COVID-19 on head and neck cancer diagnosis and disease extent. Head Neck. 2021;43(6):1890-1897. doi:10.1002/hed.26665